Search International and National Patent Collections

30. (WO2009004302) USE OF TETRAHYDROCANNABINOL AND/OR CANNABIDIOL FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE

Pub. No.:    WO/2009/004302    International Application No.:    PCT/GB2008/002183
Publication Date: Fri Jan 09 00:59:59 CET 2009 International Filing Date: Thu Jun 26 01:59:59 CEST 2008
IPC: A61K 31/352
A61K 36/185
A61P 37/00
Applicants: GW PHARMA LIMITED
ROBSON, Philip
GUY, Geoffrey
PERTWEE, Roger
JAMONTT, Joanna
Inventors: ROBSON, Philip
GUY, Geoffrey
PERTWEE, Roger
JAMONTT, Joanna
Title: USE OF TETRAHYDROCANNABINOL AND/OR CANNABIDIOL FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
Abstract:
The present invention relates to the use of a substantially pure tetrahydrocannabinol (THC) or a THC containing extract in which THC is a primary cannabinoid, in the manufacture of a medicament for use in the treatment of an inflammatory bowel disease. A further embodiment of the invention relates to the use of a substantially pure cannabidiol (CBD) or a CBD containing extract in which CBD is a primary cannabinoid, in the manufacture of a medicament for use in the treatment of an inflammatory bowel disease. Additionally the substantially pure cannabidiol (CBD) or a CBD containing extract in which CBD is a primary cannabinoid are used in the manufacture of a medicament for use as an adjunct therapy in the treatment of an inflammatory bowel disease.